FOXO1 and glioblastoma: When gene expression analysis was extended to clinical tissue samples from low-grade glioma (LGG) and GBM, elevated levels of CEBPD, BMP7, FOXO1, and LPL were observed in both tumor types, except for CEBPD, which was not significantly upregulated in LGG, suggesting a metabolic reprogramming that favors adipogenic and lipogenic signaling.